Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,279 | 9,217 | 2,239 | 1,711 | 8,500 |
| Marketable Securities | 80,165 | 0 | N/A | N/A | N/A |
| Receivables | 73 | 247 | 72 | 292 | 232 |
| TOTAL | $116,940 | $9,984 | $2,738 | $2,475 | $9,298 |
| Non-Current Assets | |||||
| PPE Net | 5 | 7 | 12 | 2 | 531 |
| Other Non-Current Assets | 191 | 228 | 298 | 360 | 414 |
| TOTAL | $196 | $235 | $310 | $362 | $946 |
| Total Assets | $117,136 | $10,220 | $3,048 | $2,837 | $10,244 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 523 | 924 | 765 | 530 | 1,260 |
| Accrued Expenses | 825 | 1,318 | 660 | 395 | 635 |
| Other current liabilities | N/A | N/A | 4,195 | 176 | 893 |
| TOTAL | $1,458 | $2,606 | $5,905 | $1,377 | $3,061 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 2,657 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 141 |
| TOTAL | $N/A | $N/A | $2,657 | $N/A | $141 |
| Total Liabilities | $1,458 | $2,606 | $8,561 | $1,377 | $3,202 |
| Shareholders' Equity | |||||
| Common Shares | 15 | 10 | 13 | 13 | 12 |
| Retained earnings | -119,859 | -111,662 | -94,344 | -85,384 | -79,097 |
| TOTAL | $115,678 | $7,613 | $-5,513 | $1,460 | $7,042 |
| Total Liabilities And Equity | $117,136 | $10,220 | $3,048 | $2,837 | $10,244 |